DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Uschner F, Nikolova I, Klein S. , et al.
The multikinase inhibitor regorafenib improves portal hypertension in presence and absence of cirrhosis in rats.

J Hepatol 2016;
64: S134-S135

Download Bibliographical Data

Search in: